NY A09662 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 27 2024 - 25% progression
Action: 2024-03-27 - referred to insurance
Pending: Assembly Insurance Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Sponsors


History

DateChamberAction
2024-03-27Assemblyreferred to insurance

Same As/Similar To

S08367 (Same As) 2024-03-07 - PRINT NUMBER 8367A

New York State Sources


Bill Comments

feedback